Adhere+ Transforms Chronic Care with Remote Therapeutic Monitoring
With Adhere+, providers bridge the gap between growing patient needs
and limited resources - all while staying ahead of compliance and innovation

Why Remote Therapeutic Monitoring (RTM) Matters Now

The Need: The rising demands of chronic care outpace available resources, leaving patients at greater risk. RTM bridges this gap by supporting providers with actionable tools leading to better patient outcomes.

The Opportunity: CMS-adopted AMA CPT codes now reimburse RTM services, offering practices a financially sustainable way to enhance care delivery and operational efficiency.

The Future: Remote Therapeutic Monitoring is setting a new standard in proactive healthcare, enabling providers to intervene earlier and improve lives.

Adhere+ Leads the Way in RTM

4.8 MILLION

1.2 MILLION

8

ePROs

RTM Patient Interactions

NIH/NImH Studies

Simplified Compliance, Scalable Solutions

Adhere+ is a research-founded RTM platform enhanced by the AARC™ Framework, automating audit-ready documentation to streamline regulatory compliance and reduce administrative burden.

Adhere+ also adapts to your practice’s needs, supporting specialties like pain management, bariatrics, and chronic disease care. It empowers providers to deliver proactive, patient-centred care while improving outcomes and engagement.

Designed by Experts for
Real-World Challenges

Designed by healthcare professionals and seasoned medtech executives, Adhere+ tackles the real-world challenges faced by providers and administrators. Our RTM protocols are crafted by physicians for physicians, ensuring they are practical, effective, and rooted in real medical practice.

These protocols are continuously refined with input from practicing providers to enhance workflows, elevate care quality, and deliver measurable results.

Proven Benefits for All Healthcare Stakeholders

For Providers

For Patients

For Executives

Simplify Workflows, Improve Patient Care
Better Support for Better Patient Health
Align Innovation with
Business Goals
  • Proactive Engagment:
    Maintain consistent connections with patients, ensuring adherence and enabling timely interventions
  • Actionable Insights:
    Leverage automated documentation and real-world evidence to support clinical decisions and compliance
  • Customizable for Your Practice:
    Our RTM protocols, designed by providers in their medical specialties, can be quickly aligned with your practice’s approach. Ask patients the questions that fit your workflow, making Adhere+ a seamless extension of your practice
  • Clear Communication:
    Strengthens the provider-patient relationship with meaningful engagement and accessible care.
  • Reduced Stress and Anxiety:
    Simplifies care plans, helping patients feel supported and confident in their health journey
  • Built to Enhance Outcomes:
    Daily monitoring and timely interventions are designed to support better health results and an improved quality of life
  • Reimbursement Opportunities:
    Monetize difficult-to-capture and previously uncompensated efforts like patients phone calls, emails and clinical follow-ups to unlock new revenue streams
  • Scalability and Growth:
    Seamlessly expand into new specialties and markets with a platform designed for the future of healthcare
  • Compliance and Transparency:
    Ensure audit readiness and protect your practice with automated documentation that meets regulatory requirements

Results:
More time for patient care and improved clinical efficiency

Results:
Healthier, happier patients who feel connected, supported and empowered in their care journey

Results:
Scalable, reimbursable care that drives growth while keeping teams focused on what matters most – patient care

The ADHERE+ TEAM

100+ years of proven leadershipwith deep experience in healthcare, technology, and commercialization

Jim Bridenstein
CEO
  • $8B+ Financial Exists
  • Launched World's First PDT - PEAR Therapeutics
  • Led Kyphon to $4.2B Acquisition
  • Added $1.4B value - CSI
Andy Plummer
CFO
  • Grew Thomson Reuters Special Services to $130M Revenue
  • 14 Years Financial Leadership
  • Expert in Startups & Equity Ventures
Dan Cohen
President, Co-Founder
  • $3B Breast Implant Acquisition
  • 11 FDA-Approved Abuse Deterrent Products
  • FDA Approvals: Apadaz, VBLOC, Juvederm
  • $44B ERLA/IR Market Impact
Scott Cashon
CTO
  • $20B Travel Spend Platform
  • VA/DoD Mobile Engagement Design
  • Scalable VoIP Telephony Platform
  • Global Army Base Management UI
Dr. Lynn Webster
CMO Emeritus
  • 300+ Peer-Reviewed Publications
  • Hundreds of clinical trials
  • Past President of AAPM
Jeff Huynh
VP, Marketing
  • Scaled MedTech Startups from $0 to $50M+
  • Global Launches in $2B+ Markets: US, EU, AUS
  • 6 Regulatory Approvals Secured
  • 2 Pivotal IDE Trials
info@adhereplus.com • (202) 503-4355 • 6128 George Ave #5080, Washington DC 20011
Copyright © 2026 Adhere+ Corporation. All rights reserved